SCHEMBL7846110

SCHEMBL7846110

CCCCC(CO)(CCCC)N(C)S(=O)(=O)c1ccc(N(C)C)cc1Cc1ccc(OC)cc1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 3/20 0.37
KEAP1 Q14145 4/20 0.36
NFE2L2 Q16236 4/20 0.36
LMNA P02545 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
CNR1 P21554 2/20 0.33
CALM1 P0DP23 1/20 0.33
ACLY P53396 1/20 0.33
SLC10A2 Q12908 3/20 0.33
LTB4R2 Q9NPC1 1/20 0.33
TAS2R14 Q9NYV8 1/20 0.33
APP P05067 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
TSHR P16473 1/20 0.32
CYP2C19 P33261 1/20 0.32
BMP1 P13497 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7846525 0.87 CNR2 (0.40) CNR2KEAP1NFE2L2LMNAMEN1
SCHEMBL7848425 0.86 CNR2 (0.33) CNR2KEAP1NFE2L2MEN1KMT2A
SCHEMBL7837755 0.85 CNR2 (0.35) CNR2KEAP1NFE2L2MEN1KMT2A
SCHEMBL7837233 0.82 MEN1 (0.35) CNR2LMNAMEN1KMT2ACALM1
SCHEMBL7848483 0.81 LMNA (0.37) LMNAKMT2ACNR1SLC10A2CYP1A2
SCHEMBL6200975 0.77 CNR2 (0.33) CNR2KEAP1NFE2L2MEN1KMT2A
SCHEMBL7846237 0.77 APP (0.34) CNR2LMNAMEN1KMT2ACNR1
SCHEMBL7845257 0.76 CNR1 (0.37) CNR2KEAP1NFE2L2LMNAMEN1
SCHEMBL7846899 0.76 CNR2 (0.38) CNR2KEAP1NFE2L2LMNAMEN1
SCHEMBL7846766 0.75 CNR2 (0.40) CNR2KEAP1NFE2L2LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1155007-A2 1,2-BENZOTHIAZEPINES FOR THE TREATMENT OF HYPERLIPIDEMIC DISEASES G.D. Searle LLC (US) 2001-11-21 EP disclosed
WO-2000047568-A2 1,2-BENZOTHIAZEPINES FOR THE TREATMENT OF HYPERLIPIDEMIC DISEASES G.D. SEARLE LLC (US) 2000-08-17 WO disclosed